ResearcherMassachusetts General HospitalNo recent work listed
Naomi M. Sell
Matched on ORCID iD 0000-0003-4397-1627; OpenAlex author ID A5082432091. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 5
- Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer. Co-author DOI 10.1016/j.hpb.2023.04.010↗
- Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancre… Co-author DOI 10.1016/j.surg.2022.05.024↗
- Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare population with pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2020.03.035↗
- Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001590↗
- ASO Author Reflections: Staging Laparoscopy Improves Overall Survival of Patients with Pancreatic Adenocarcinoma Found to Have Occult Metastatic Disease. Co-author DOI 10.1245/s10434-018-7049-6↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Motaz Qadan · 4 shared papers, 2020–2023 · strength 0.59
- Paper Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pan… DOI 10.1016/j.hpb.2023.04.010↗
- Paper Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall s… DOI 10.1016/j.surg.2022.05.024↗
- Paper Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001590↗
- Cristina Rosa Ferrone · 4 shared papers, 2018–2022 · strength 0.52
- Paper ASO Author Reflections: Staging Laparoscopy Improves Overall Survival of Patients with Pancreatic Adenocarcinoma Found … DOI 10.1245/s10434-018-7049-6↗
- Paper Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall s… DOI 10.1016/j.surg.2022.05.024↗
- Paper Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001590↗
- Keith D. Lillemoe · 3 shared papers, 2020–2022 · strength 0.35
- Paper Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall s… DOI 10.1016/j.surg.2022.05.024↗
- Paper Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001590↗
- Paper Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare popula… DOI 10.1016/j.amjsurg.2020.03.035↗
- Maximiliano Servín-Rojas · 1 shared paper, 2023 · strength 0.24
- Carlos F. Fernandez-del Castillo · 2 shared papers, 2020–2022 · strength 0.24
- Paper Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall s… DOI 10.1016/j.surg.2022.05.024↗
- Paper Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare popula… DOI 10.1016/j.amjsurg.2020.03.035↗
- Andrew Louis Warshaw · 2 shared papers, 2020 · strength 0.22
- Paper Evaluation of Pathologic Response on Overall Survival After Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. DOI 10.1097/mpa.0000000000001590↗
- Paper Variation in long-term oncologic outcomes by type of cancer center accreditation: An analysis of a SEER-Medicare popula… DOI 10.1016/j.amjsurg.2020.03.035↗
- Vinod P. Balachandran · 1 shared paper, 2022 · strength 0.13
- Guoliang Qiao · 1 shared paper, 2022 · strength 0.13
- Thomas P. Hank · 1 shared paper, 2022 · strength 0.13
- T. Peter Kingham · 1 shared paper, 2022 · strength 0.13
- Michael Ian D'Angelica · 1 shared paper, 2022 · strength 0.13
- Quisette P. Janssen · 1 shared paper, 2022 · strength 0.13
- Jeffrey A. Drebin · 1 shared paper, 2022 · strength 0.13
- William R. Jarnagin · 1 shared paper, 2022 · strength 0.13
- Alice Chia-Chi Wei · 1 shared paper, 2022 · strength 0.13
- Theodore Sunki Hong · 1 shared paper, 2020 · strength 0.11
- Carlos Fernández-del Castillo · 1 shared paper, 2020 · strength 0.11
- Lawrence Scott Blaszkowsky · 1 shared paper, 2020 · strength 0.11
- Zhi Ven Fong · 1 shared paper, 2020 · strength 0.11
- Angela C. Tramontano · 1 shared paper, 2020 · strength 0.11
- Chin Hur · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.